SUNNYVALE, CA -- (Marketwire) -- 08/18/08 -- Conformia, the market leader and innovator ofenterprise solutions for product/process lifecycle management (PPLM) forregulated process manufacturing industries, today announced it hasintegrated its solution into the IBM platform to provide an end-to-endsolution for drug development to the pharmaceutical industry. The solutionincorporates service oriented architecture (SOA) capabilities that havebeen validated by IBM. Conformia's SOA approach enables other applicationsrunning on the IBM stack and infrastructure to exchange crucialpharmaceutical data with Conformia's products. Furthermore, data fromnon-IBM products can now be integrated into Conformia and IBM productstacks creating the first commercial off-the-shelf, integrated informationenvironment solution for pharmaceutical and biotech drug development.Conformia fulfilled the IBM PartnerWorld® SOA validation criteria fortheir solution in December, and is working with IBM to deliver both thestrategic business transformation and the commercial off-the-shelf softwaresystems that pharmaceutical developers need to support sustainability oftheir transformation strategies. With the Conformia SOA platform, drugdevelopers will be able to reduce development lifecycles, increaseoperational visibility and traceability, improve product quality, anddecrease the costs associated with regulatory non-compliance -- all whileachieving major gains in data integration.
Working together, Conformia and IBM provide the pharmaceutical industrywith enterprise software on a reliable, robust technology stack that linksdata around early experiments, pilot plant scale-up as well as full-scalemanufacturing, along with proven business processes and deploymentcapabilities.
"As one of the most heavily regulated and complex industries, thepharmaceutical sector presents a myriad of unique challenges toorganizations during their product-development lifecycles, and, until now,few have stepped forward to help," said Dan Pelino, general manager, IBMGlobal Healthcare and Life Sciences. "Together, Conformia and IBM arehelping to deliver a clear path for these organizations to follow -- onethat allows them to create an integrated data and information environmentresulting in more effective knowledge-management programs, which they arenow demanding."
"Combining our deep pharmaceutical and biotech expertise with IBM'sstrength in pharmaceutical industry business transformation delivers agroundbreaking new approach to help companies implement new developmentstrategies such as the Quality by Design Paradigm or the ICH QualityVision. This helps solve some of the biggest issues in drug development,"said Anjali Kataria, founder and chief marketing officer of Conformia. "Ourwork with IBM both validates and strengthens our continued dedication tomaking product development more efficient so scientific leadership can domore with the same resources."
About Conformia
Conformia Software is the leading provider of product/process lifecyclemanagement (PPLM) software solutions to regulated process industriesincluding life sciences. Conformia solutions enable faster time to market,reduced costs and decreased risk. As a company, Conformia remains a thoughtleader in addressing the most pressing issues facing pharmaceuticaldevelopment teams across the globe such as implementation of ICH QualityVision. For more information, go to: www.conformia.com.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Media Contacts:
Schwartz Communications, Inc.
Laurie Falconer or Michelle Reingold
415-512-0770
conformia@schwartz-pr.com
